Healing AIDS is out of reach, but ending AIDS is just around the corner
Release date: 2015-10-14 Francoise Barre-Sinoussi, co-discoverer of HIV and winner of the 2008 Nobel Prize in Medicine, made an explosive speech in an interview to announce retirement. She said that "healing AIDS is an impossible task." Dr. Barre-Sinoussi has made great achievements in the field of AIDS treatment. She worked at the Pasteur Institute and her career has almost always been spent on finding ways to cure AIDS and fight HIV. As the president of the International AIDS Society, she used her own knowledge and years of research to lead the whole society to the unswervingly on the road to treating AIDS. However, curing AIDS is out of reach. Barre-Sinoussi's retired testimony is not unreasonable. Scientists have been fighting the virus since the isolation of HIV in 1983. Barre-Sinoussi said treating AIDS is a challenging, time-consuming and labor-intensive process. Although "Berlin patient" and "Mississippi baby" have brought hope, they are all short-lived. However, we should not be discouraged because of the years of research by researchers and the joint efforts of thousands of volunteers to fight AIDS from cure to the end of AIDS infection and death. Treating AIDS: The Miracle of Antiretroviral Drugs At present, the drugs against AIDS are mainly antiretroviral drugs, which save lives by preventing serious complications and infections, and are much better than the past therapeutic drugs. It is a miracle of scientific progress now. The World Health Organization has launched a "fixed-dose combination" that includes three antiretroviral drugs that are combined in a single drug to make the treatment easier and good resistance to control the development of AIDS. Lifelong antiretroviral drugs are the basis for good control of AIDS development and can turn AIDS into a manageable chronic disease. Moreover, the AIDS medical diagnosis system is almost perfect than all other modern medical fields. The mortality rate of AIDS worldwide is declining, including some low-income countries. A recent report, a randomized clinical trial of antiretroviral drugs in 35 countries, randomized the subjects and delayed the time they started drug treatment. The report shows that delays in treatment time can significantly increase the probability of multiple serious diseases including cancer and tuberculosis. A number of countries participating in the trial, regardless of high income or low income, have similar results. This suggests that antiretroviral therapy (ART) is universal and involves ART in the early stages of the disease, with a 44% reduction in mortality or the incidence of serious concurrent disease. Reasonable treatment can reasonably control the development of AIDS and viral infection. Control AIDS epidemic: develop guidelines and expand targets Integrating the above data, ART treatment can provide medical treatment to all HIV carriers around the world. Many countries have accepted such strategies, including the United States, France, Spain and Brazil. This fall, the World Health Organization issued guidelines to support patients in low-income countries for treatment. UNAIDS has set a 2015 goal of getting 15 million people living with HIV for ART. Currently, this goal has been achieved. In order to completely control AIDS, the Planning Department has set a goal for 2020, the “90-90-90†plan, which will be realized in the next five years: 90% of AIDS patients are tested and know their condition; 90% know themselves Patients with AIDS will receive ART treatment; 90% of AIDS patients will suppress the disease. The "90-90-90" plan is unrealistic? Some people think that the "90-90-90" plan is too idealistic. However, these critics have only made simple mathematical calculation errors: 90% of 90% of 90% of the final result is 73%, which means 2020 The ultimate goal is for 73% of AIDS patients. This is not an unrealistic determination, and it is not too ambitious to target 27% of AIDS patients. The "90-90-90" program means an urgent need to accelerate the lives of millions of people. Currently, several high-income cities are close to their targets. Analysis shows that high-burden countries need to accelerate the promotion of ART treatment to avoid millions of premature deaths and new HIV infections. If we start to take action, tragedies can often be contained. In order to achieve the great goal of “90-90-90â€, the International Association of AIDS Care Services (IAPAC) and UNAIDS signed the 2014 Paris Declaration with 47 cities and agreed to cooperate with medical institutions and popular organizations to rapidly increase HIV testing. The spread of treatment to reach the goal of ending the HIV infection. challenge Achieving the goal of ending the AIDS epidemic is not easy, and we will face more adjustments. First, we must be aware of the need to continue to develop an objective, evidence-based prevention strategy. For ART treatment, no risk of treatment, no problem of virus resistance. Second, we must ensure that AIDS patients know and choose the right. It is their right to choose treatment and refuse treatment. Regulations against AIDS must be sound and complete. Finally, we must be convinced that we have the ability and method to end AIDS transmission. In the future, we can save millions of lives and we can no longer fear HIV. All commitments, statements, and plans are not just a paperwork, they need to be implemented in action. Now, five years from 2020, it is time to take action. Source: Bio-Exploration
Our company offers variety of products which can meet your multifarious demands.including API Powder.Pharmaceutical Intermediates.Vitamins Powder.Plant Extracts.Food Additive.Peptide Powder and so on We adhere to the management principles of "quality first, customer first and credit-based" since the establishment of the company and always do our best to satisfy potential needs of our customers. Our company is sincerely willing to cooperate with enterprises from all over the world in order to realize a win-win situation since the trend of economic globalization has developed with anirresistible force.
product Photo:
L-Carnitine,Anti-Aging Bovine Collagen Powder,Skin Whitening L-Glutathione Powder,Nasal Spray Bottles Shaanxi YXchuang Biotechnology Co., Ltd , https://www.peptide-nootropic.com
1) L-carnitine Powder can Promote normal growth and development;
2) L-carnitine Powder can Treat and possibly prevent cardiovascular disease;
3) L-carnitine Powder can Treat muscle disease;
4) L-carnitine Powder can Help build muscle;
5) L-carnitine Powder can Protect against liver disease;
6) L-carnitine Powder can Protect against diabetes;
7) L-carnitine Powder can Protect against kidney disease;
8) L-carnitine Powder can Aid in dietingDescri
The body produces carnitine in the liver and kidneys and stores it in the skeletal muscles, heart, brain, and other tissues. But its production may not meet the needs under certain conditions such as increased energy demands and therefore it is considered a onditionally essential nutriention. There are two forms (isomers) of carnitine, viz. L-carnitine and D-carnitine, and only the L-isomer is biologically active.